On the 9th of October 2021, Vincent Kemme, founder of the Institute ‘Biofides’ for biology and faith, and editor in chief of Acta Medica Catholica, bulletin of the Belgian Catholic Medica Association, was invited to give a talk on ‘End of Life issues in the Low Countries, at the occasion of the National Meeting of the Catholic Medical Association in Portugal,
Read more ➜
Challenges of competence and compassion in contemporary medicine
Assisi, 27-29 May 2022
Extended board meeting of the European Federation of Catholic Medical Associations (FEAMC), including a symposium, to be held in Asissi, Italy, open for members of associated associations.
Venue: Domus Pacis Assisi
Visit to Francescan places (San Damiano,
Read more ➜
The next international congres of the World Federation of Catholic Medical Associations (FIAMC), under the presidency of Professor Dr. Bernard Ars, will be held in Rome, September 15 – 17th, 2022.
Theme:
Medicine: reparative or transformative ?
The mission of the christian physician.
Read more ➜
Monday, October 4, 2021
UCLouvain – Faculty of Medicine – Brussels Campus
Description and program
Over the last few years, in Europe and Western countries, freedom of conscience of healthcare professionals has been progressively challenged as legal access to certain ethically controversial practices has expanded.
Read more ➜
Since the World Health Organization first alerted the world to the existence of a mysterious group of pneumonia cases in Wuhan, China, researchers have already developed more than two hundred vaccine candidates to combat the expansion of the coronavirus SARS.CoV.2. After ten months of speedy development, the competition between the various laboratories for producing an efficacious and safe vaccine against the new coronavirus has taken a decisive turn and has resulted in a promising result.
Read more ➜
John Paul II Medical Research Institute – Coralville, Iowa – USA
There are several ethical and scientific concerns about “Operation Warp Speed” vaccines. First, most of these vaccines are using an aborted fetal cell in either vaccine design, testing or manufacturing. Pfizer and Moderna’s vaccines have received an Emergency Use Authorization (EUA) from the Food and Drug Administration (FDA).
Read more ➜